Latest filing published 30 Apr 2026 for Allarity Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Jeffrey S. Ervin across 2 companies, led by IMAC Holdings, Inc. and Allarity Therapeutics, Inc. Over a trading history stretching from 21 May 2021 to 28 January 2026, the count stands at 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 30 April 2026, reports a share grant in Allarity Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations